Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prospects for cancer genetics

R A Weinberg1

  • 1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.

Cancer Surveys
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Discovering cancer-related genes requires novel approaches. Current methods for identifying oncogenes and tumor suppressor genes have limitations, necessitating advancements in gene transfer and genomic analysis for future cancer genetics progress.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells.

Oncogene·2015
Same author

Thrombospondin-1 repression is mediated via distinct mechanisms in fibroblasts and epithelial cells.

Oncogene·2014
Same author

Enhanced elimination of oxidized guanine nucleotides inhibits oncogenic RAS-induced DNA damage and premature senescence.

Oncogene·2010
Same author

The evolving portrait of cancer metastasis.

Cold Spring Harbor symposia on quantitative biology·2006
Same author

Derivation of human tumor cells in vitro without widespread genomic instability.

Cancer research·2001
Same author

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Cell·2001
Same journal

Future directions: bladder cancer.

Cancer surveys·2004
Same journal

Radiotherapy and chemotherapy for invasive bladder cancer.

Cancer surveys·2004
Same journal

The role of surgery in the multimodality treatment of bladder cancer.

Cancer surveys·2004
Same journal

Clonal development of bladder cancer and its relevance to the clinical potential of HLA antigen and TP53 based gene therapy.

Cancer surveys·2004
Same journal

Clinical evaluation of immunotherapy: are there differences between papillary and flat in situ bladder cancer?

Cancer surveys·2004
Same journal

Molecular biological changes in bladder cancer.

Cancer surveys·2004
See all related articles

Area of Science:

  • Cancer genetics
  • Molecular oncology
  • Genomic instability

Background:

  • Over the past two decades, various strategies have been employed to identify genes implicated in tumorigenesis.
  • Existing methods for oncogene and tumor suppressor gene discovery face technical limitations and inefficiencies.

Purpose of the Study:

  • To address the limitations of current gene discovery techniques in cancer genetics.
  • To explore novel approaches for identifying oncogenes, tumor suppressor genes, and genes involved in cancer progression.

Main Methods:

  • Review of existing strategies including retrovirus-mediated transduction, gene transfection, and loss of heterozygosity detection.
  • Discussion of potential improvements in gene transfer, cloning techniques, and data analysis for gene discovery.

Related Experiment Videos

  • Consideration of germline mutation analysis and its challenges (penetrance, polygenic traits).

    • Main Results:

    • Current methods for oncogene and tumor suppressor gene identification are inefficient and limited in sensitivity.
    • Improvements in gene transfer, cloning, and data analysis are expected to reveal new oncogenes and tumor suppressor genes.
    • Future research will focus on genes involved in genomic integrity maintenance and those driving cancer invasiveness and metastasis.

    Conclusions:

    • Novel approaches and technological advancements are crucial for continued progress in cancer genetics.
    • Understanding genes related to genomic integrity and metastasis will be a key focus in the next decade.
    • Further research is needed to uncover the full spectrum of genes contributing to cancer development and progression.